Arecor Therapeutics (LON:AREC) Trading Down 1.3% – Here’s Why

Arecor Therapeutics plc (LON:AREC)’s stock price traded down 1.3% during mid-day trading on Tuesday . The stock traded as low as GBX 74 ($0.91) and last traded at GBX 74 ($0.91). 204 shares changed hands during mid-day trading, a decline of 90% from the average session volume of 2,132 shares. The stock had previously closed at GBX 75 ($0.93).

Arecor Therapeutics Trading Down 1.0 %

The firm has a market capitalization of £27.66 million, a P/E ratio of -261.61 and a beta of -0.18. The company has a current ratio of 1.37, a quick ratio of 6.24 and a debt-to-equity ratio of 5.51. The stock has a 50 day simple moving average of GBX 73.66 and a 200-day simple moving average of GBX 82.01.

About Arecor Therapeutics

Arecor Therapeutics plc is a biopharmaceutical company transforming patient care by bringing innovative medicines to market. Through the enhancement of existing medicines using our Arestat™ technology, we are developing a broad portfolio of therapies as part of our proprietary pipeline and through partnerships with leading pharmaceutical and biotech companies.